Ah, SLE—the ultimate "great imitator" in medicine! It's a classic for the UKMLA AKT because it can affect literally any organ system, making it a diagnostic challenge. Let me grab some high-yield lessons to get us started on the essentials.

When we talk about diagnosing SLE, we have to start with the Antinuclear Antibody (ANA) test. Think of it as the "gatekeeper"—it's incredibly sensitive (about 95-99%), so if it's negative, SLE is very unlikely. However, it's not very specific, as it can be positive in other autoimmune conditions or even healthy people.

The 2019 ACR/EULAR criteria actually require a positive ANA (titer ≥1:80) as an entry criterion. Once that's met, you look for clinical and immunological features, each assigned a weight. You need a total score of 10 or more to classify it as SLE. Let me find a good summary of those diagnostic criteria for you.

Here is a breakdown of the clinical and immunological features we look for in SLE. Remember, the ANA is the entry point, but more specific antibodies like anti-dsDNA and anti-Smith are the "smoking guns" for diagnosis.

Management of SLE

Management is all about controlling flares and preventing long-term organ damage. Here’s the high-yield breakdown:

1. Lifestyle & Prevention

• Sun Protection: UV light is a major trigger for flares. High-factor sunscreen and protective clothing are essential.
• Cardiovascular Risk: SLE is a pro-inflammatory state, so managing BP, lipids, and smoking is crucial.

2. Pharmacological Management

• Hydroxychloroquine (HCQ): The "gold standard." Almost every patient with SLE should be on HCQ unless contraindicated. It reduces flares, improves survival, and protects the kidneys.
  • Exam Tip: Patients on long-term HCQ need annual ophthalmology screening for retinopathy.
• Corticosteroids: Used for acute flares (oral or IV) to get inflammation under control quickly. The goal is always to taper to the lowest effective dose.
• Immunosuppressants: For moderate-to-severe disease or "steroid-sparing" effects:
  • Azathioprine: Often used for maintenance.
  • Mycophenolate Mofetil (MMF): Preferred for Lupus Nephritis.
  • Cyclophosphamide: Reserved for severe, organ-threatening, or life-threatening flares.
• Biologics: Belimumab or Rituximab may be used in refractory cases that don't respond to standard therapy.

Mnemonic: SOAP BRAIN MD (The classic ACR criteria) Serositis, Oral ulcers, Arthritis, Photosensitivity, Blood (cytopenias), Renal (proteinuria), ANA positive, Immunologic (dsDNA/Sm), Neurologic, Malar rash, Discoid rash.

Does that help clear up the diagnostic approach and management for your AKT prep?